Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.
about
Treatment of infantile spasmsTreatment of infantile spasmsTonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy.Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressantsThe potential for vigabatrin-induced intramyelinic edema in humans.Vigabatrin.Vigabatrin: a novel therapy for seizure disorders.Newer anti-epileptic drugs.Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.Vigabatrin in the treatment of epilepsy in childrenEfficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.Recent advances in the diagnosis and treatment of epilepsy.Treatment of infantile spasms.Pharmacology of vigabatrin.Measurement of patient compliance and the interpretation of randomized clinical trials.CNS adverse events associated with antiepileptic drugs.Pharmacotherapy of epilepsy: state of the art and developments.Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.Mechanism of action of vigabatrin: correcting misperceptions.Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.Some aspects of prognosis in the epilepsies: a review.The Cochrane collaboration: systematic reviews and their relevance to epilepsy. The Cochrane Epilepsy Network.Optimizing the indication of vigabatrin in children with refractory epilepsy.Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions.A multicentre study of vigabatrin for drug-resistant epilepsy.Effect of food on the absorption of vigabatrin.Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy.Time course of the GABAergic effects of vigabatrin: is the time course of brain GABA related to platelet GABA-transaminase inhibition?Vigabatrin: clinical evidence supporting rational polytherapy in management of uncontrolled seizures.Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patients.Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.Effect of vigabatrin on the electroencephalogram in rats.Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy
P2860
Q24202185-C41553D0-B48A-484C-B66B-DA90C97F7AE7Q24241001-F28F4C15-A62F-4970-9BF7-9F894457329AQ27692644-DD66B0C6-45CA-467D-9F41-A593698EDF9CQ30887852-3E8E844A-F0B8-4E2F-BC7E-9ACA0B20E4AAQ31535676-22454EC9-26A9-4F3A-B795-5A99096F94EDQ33756754-63F6D09C-E7CC-4D21-B492-6EAF210D70F5Q33814543-FD1E24FF-4063-4FF8-B772-FA45D8A2BD51Q33929232-72F019AF-350B-4AD5-B676-7D17BAE548EEQ34366904-EC21EF8C-8AB6-47D2-9C26-19D9DD49C107Q34396902-B08E1448-AEA5-4F91-95B1-20387C492BDCQ34396923-CBF79CE1-2703-4C91-8BE6-A58FECFF694CQ34488961-22822414-ABE1-4127-A76E-8403020DB070Q34698993-6402254A-CC1C-4AA4-B75F-3B0D48E7272AQ36223272-37CEA359-84F8-407E-8B56-76B9300B3CB2Q37126290-0EA66F44-C303-42D4-89EB-3A89CE33BF06Q37242600-3608D00C-FC05-47D7-8B44-0C3E1035EC5FQ37374673-E7B9B6AD-4C4E-446B-8F6B-564E5287C034Q37642768-20C596DD-FBC7-40CB-99C8-91FAC4B105EBQ37953574-9059FDB5-B08B-45F6-A6AA-98571793FD33Q37953578-A985C114-66F0-4E73-A8DE-0C82D252C228Q40781638-E957C1B6-CBD3-44F5-83B2-17D548732F4FQ41122734-2BB4F738-781B-4BC8-8D74-267306D15998Q41514405-FD5A304B-B739-44AC-91CF-4425800C82ABQ41690392-D9EB7764-FFCC-4B7D-95F5-9EDF2B9062B8Q42017013-047106F2-9783-49AD-BDC5-CB8C457F8286Q43222145-4BBA3BBD-3D53-4A30-AD0C-C8288EA40303Q43429100-E4F2B572-3DCB-4030-9460-9A2868763951Q45103257-FEA9D238-5FBB-452C-B179-57DF446040FBQ48135407-869A1AAE-D8FB-49FB-8806-BFFA756F4E48Q48161913-309C125A-C0BF-4950-8969-D161DEAE29CEQ48165155-A08E40F3-F37A-4883-ACD6-8E6A8188C728Q48296941-905F6985-1C03-40E1-AC6A-40CDAECCDCD6Q48363107-5316E2D0-EA07-4977-952F-DA852E5E57AEQ48437669-07249E82-C99C-4BC7-94B4-9D7D85B5FFFAQ48553738-1D8531F4-5477-4B00-BF81-0BD003D0FD9CQ51153543-379DB760-DC6B-4FF0-A0A2-D2D257FF7E21Q54231363-DF3586AB-A0A5-4AC5-94B5-ECBB70F93533Q54263462-D61473E6-434C-45BE-9C37-6638779A40FFQ57626540-7A13B9DC-756B-44A6-B54A-A05A7C2C3317
P2860
Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Meta-analysis of European plac ...... in in drug resistant epilepsy.
@en
type
label
Meta-analysis of European plac ...... in in drug resistant epilepsy.
@en
prefLabel
Meta-analysis of European plac ...... in in drug resistant epilepsy.
@en
P2860
P1476
Meta-analysis of European plac ...... in in drug resistant epilepsy.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03469.X
P407
P478
27 Suppl 1
P577
1989-01-01T00:00:00Z